Skip to main content

Insights

Does TRICARE Cover TMS Therapy?

Quick answer

Yes. TRICARE covers transcranial magnetic stimulation (TMS) for major depressive disorder, with pre-authorization required. To qualify, beneficiaries generally need to be at least 15 years old, have a documented PHQ-9 score of 15 or higher within the past four weeks, and have not responded to at least two antidepressants from different classes plus a proper trial of evidence-based psychotherapy. Initial approval allows up to 36 sessions over 90 days. TMS is not covered by TRICARE for any condition other than major depressive disorder.

What TRICARE actually covers

TRICARE's clinical policy for TMS is narrower than many people expect, and knowing the exact criteria before you pursue treatment can save weeks of back-and-forth.

The core rule: TRICARE covers TMS (also called repetitive TMS or rTMS) for major depressive disorder only. It is not covered for any other condition — not PTSD, not anxiety disorders, not OCD — even though TMS is used clinically for some of those conditions in other contexts. Pre-authorization is required for every course of TMS.

The initial approval criteria

For an initial request, TRICARE's review can approve up to 36 sessions delivered over 90 days when all of the following are documented:

Age. The beneficiary is 15 years of age or older. This is notable — TMS itself is FDA-cleared for adolescents 15 and up, and TRICARE's policy matches that age line, which makes covered treatment a real option for teens in military families.

Diagnosis. A diagnosis of major depressive disorder made in accordance with the current DSM, following a medical evaluation. The treating provider must be a TRICARE-authorized mental health provider trained and capable of performing TMS.

Symptom severity. A documented baseline PHQ-9 score of at least 15 — the "moderately severe" range — recorded within the previous four weeks. If you haven't taken a PHQ-9 recently, you can complete one in a few minutes with our free PHQ-9 depression screener. A self-screen isn't the official documentation TRICARE needs, but it tells you immediately whether your symptoms are in the range the policy requires, and it gives you a concrete number to bring to your evaluation.

Treatment-resistant depression. This is the criterion that trips people up most, and it has two parts:

First, a documented nonresponse — less than 25% improvement in depression symptoms or scores — to at least two different antidepressants from different pharmacologic classes (for example, an SSRI and an SNRI, or an SSRI and bupropion). Each medication must have been prescribed at up to maximally indicated doses, no less than the recognized minimum therapeutic dose, and taken for six or more weeks — unless significant side effects made that impossible or the medications were contraindicated.

Second, nonresponse to a properly conducted episode of evidence-based psychotherapy, such as a formal trial of cognitive behavioral therapy or interpersonal therapy.

If your medication history is spread across several providers or a few PCS moves, gathering this documentation is often the slowest part of the process. It's worth starting early.

No contraindications. The policy lists specific exclusions: a history of seizures; ferromagnetic material anywhere in the head other than the mouth (cochlear implants, brain stimulators or electrodes, aneurysm clips, plates, metallic dyes in some tattoos); a cardiac pacemaker, implanted defibrillator, or implanted medical pump; severe cardiovascular disease; and a prior episode of 30 TMS treatments that did not produce at least a 50% reduction in baseline PHQ-9 scores.

What happens after the first course

TRICARE's policy does not authorize "subsequent visits" as a continuation. If a beneficiary needs another course of TMS later, they must meet the full initial-request criteria again — including the current PHQ-9 documentation. This is different from some commercial insurance policies, so plan accordingly if you're comparing options.

What this means in practice

If you're a TRICARE beneficiary considering TMS, the practical checklist looks like this: confirm your depression is in the moderately severe range with a recent PHQ-9, pull together records of at least two adequate medication trials from different classes and a psychotherapy trial, rule out the contraindications with your provider, and make sure the clinic treating you can support the pre-authorization process from evaluation through documentation.

Coverage also depends on receiving care from a TRICARE-authorized provider. TMS Therapy Centers Colorado is a TRICARE-authorized provider; if you're considering treatment elsewhere, it's always worth confirming a clinic's status directly with TRICARE or your regional contractor before starting. Our team can walk you through the criteria above, help you understand where you stand against them, and help you verify your benefits — call 720-500-7873 or reach us at hello@tmstherapycenterscolorado.com.

If you're in crisis or having thoughts of suicide, call or text 988 (the Suicide & Crisis Lifeline) — it's free, confidential, and available 24/7.

Frequently asked questions

No. TRICARE's policy covers TMS for major depressive disorder only. TMS for any other condition — including PTSD, anxiety disorders, and OCD — is explicitly listed as not covered, regardless of how it's used elsewhere in clinical practice.

Request your free consultation

Tell us a little about what you're facing and our care team will reach out.

Take the next step

Relief is closer than it feels.

A short, no-pressure conversation with our team is the fastest way to find out if TMS, Spravato, or ketamine is right for you. Most insurance plans are accepted.